HBIO

Harvard Bioscience Inc

0.50

USD

HBIO Earnings Reports

Positive Surprise Ratio

HBIO beat 15 of 40 last estimates.

38%

Next Report

Date of Next Report

Mar 10, 2026

Estimate for Q4 25 (Revenue/ EPS)

$23.56M

$0.03

Implied change from Q3 25 (Revenue/ EPS)

+14.43%

Implied change from Q4 24 (Revenue/ EPS)

-4.05%

-50.00%

Harvard Bioscience Inc earnings per share and revenue

On Nov 06, 2025, HBIO reported earnings of 0.00 USD per share (EPS) for Q3 25, missing the estimate of 0.00 USD, resulting in a -100.00% surprise. Revenue reached 20.59 million, compared to an expected 20.40 million, with a 0.94% difference. The market reacted with a -7.29% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 4 analysts forecast an EPS of 0.03 USD, with revenue projected to reach 23.56 million USD, implying an -- of --% EPS, and increase of 14.43% in Revenue from the last quarter.

FAQ

What were Harvard Bioscience Inc's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Harvard Bioscience Inc reported EPS of $0.00, missing estimates by -100%, and revenue of $20.59M, 0.94% above expectations.

How did the market react to Harvard Bioscience Inc's Q3 2025 earnings?

The stock price moved down -7.29%, changed from $0.59 before the earnings release to $0.55 the day after.

When is Harvard Bioscience Inc expected to report next?

The next earning report is scheduled for Mar 10, 2026.

What are the forecasts for Harvard Bioscience Inc's next earnings report?

Based on 4 analysts, Harvard Bioscience Inc is expected to report EPS of $0.03 and revenue of $23.56M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.